FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The agency plans to release more information about the AI adoption initiative in June, according to the release. The AI rollout is being led by Jeremy Walsh, the FDA’s freshly tapped chief AI ...

Overview - - The U.S. Food and Drug Administration (FDA) announced that it aims to increase the agency’s use of artificial intelligence (AI) ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...

The Food and Drug Administration plans to rapidly roll out a generative AI model to assist scientific ... encourage careful testing before full adoption. The announcement spurred many questions.